Notice of Meeting, 13134-13135 [2010-5744]
Download as PDF
<![CDATA[
13134
Federal Register / Vol. 75, No. 52 / Thursday, March 18, 2010 / Notices
Dated: March 11, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–5941 Filed 3–17–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–10–0580]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Public Health Performance
Standards Program Local Public Health
Governance Assessment (OMB 0920–
0580 exp 8/31/2010)—Extension—
Office of State, Tribal, Local and
Territorial Support Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Office of State, Tribal, Local and
Territorial Support is proposing to
extend the formal, voluntary data
collection that assesses the capacity of
local boards of health to deliver the
essential services of public health.
Electronic data submission will be used
when local boards of health complete
the public health assessment.
A three-year approval is being sought
with the current data collection
instrument. The data collection
instrument has been valuable in
assessing performance and capacity and
identifying areas for improvement.
From 1998–2002, the CDC National
Public Health Performance Standards
Program convened workgroups with the
National Association of County and City
Health Officials (NACCHO), The
Association of State and Territorial
Health Officials (ASTHO), the National
Association of Local Boards of Health
(NALBOH), the American Public Health
Association (APHA), and the Public
Health Foundation (PHF) to develop
performance standards for public health
systems based on the essential services
of public health. In 2005, CDC
reconvened workgroups with these
same organizations to revise the data
collection instruments, in order to
ensure the standards remain current and
improve user friendliness. There is no
cost to the respondent, other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of respondents
Number of responses per
respondent
Average burden per response
(in hours)
Total burden hours
175
1
5
875
Date: March 11, 2010.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2010–5929 Filed 3–17–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sroberts on DSKD5P82C1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
VerDate Nov<24>2008
17:08 Mar 17, 2010
Jkt 220001
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cellular and Molecular
Neuroscience.
Date: March 29, 2010.
Time: 2:30 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jonathan K. Ivins, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4040A,
MSC 7806, Bethesda, MD 20892, (301) 594–
1245, ivinsj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Dated: March 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
[FR Doc. 2010–5951 Filed 3–17–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
E:\FR\FM\18MRN1.SGM
18MRN1
Federal Register / Vol. 75, No. 52 / Thursday, March 18, 2010 / Notices
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Medical Liability
and Safety Innovation Projects (R21)
applications are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: Medical Liability and
Safety Innovation Projects (R2l)
Date: April 2, 2010 (Open on April 2 from
8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting)
Place: Doubletree Bethesda Hotel &
Executive Meeting Center, 8120 Wisconsin
Avenue, Conference Room TBD, Bethesda,
Maryland 20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
This notice is published less than 15 days
in advance of the meeting date due to
logistical difficulties.
sroberts on DSKD5P82C1PROD with NOTICES
Dated: March 8, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010–5744 Filed 3–17–10; 8:45 am]
BILLING CODE 4160–90–M
VerDate Nov<24>2008
17:08 Mar 17, 2010
Jkt 220001
13135
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 8, 2010.
Carolyn M. Clancy,
Director.
Agency for Healthcare Research and
Quality
[FR Doc. 2010–5698 Filed 3–17–10; 8:45 am]
BILLING CODE 4160–90–M
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the Medical Liability
and Safety Demonstration Projects (R18)
applications are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: Medical Liability and
Safety Demonstration Projects (R18).
Date: March 31–April 1, 2010 (Open on
March 31 from 8 a.m. to 8:15 a.m. and closed
for the remainder of the meeting).
Place: Doubletree Bethesda Hotel &
Executive Meeting Center, 8120 Wisconsin
Avenue, Conference Room TBD, Bethesda,
Maryland 20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
Agenda items for this meeting are subject
to change as priorities dictate.
This notice is published less than 15 days
in advance of the meeting date due to
logistical difficulties.
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
In accordance with section 10(d) of
the Federal Advisory Committee Act (5
U.S.C., Appendix 2), announcement is
made of a Health Care Policy and
Research Special Emphasis Panel (SEP)
meeting.
A Special Emphasis Panel is a group
of experts in fields related to health care
research who are invited by the Agency
for Healthcare Research and Quality
(AHRQ), and agree to be available, to
conduct on an as needed basis,
scientific reviews of applications for
AHRQ support. Individual members of
the Panel do not attend regularlyscheduled meetings and do not serve for
fixed terms or a long period of time.
Rather, they are asked to participate in
particular review meetings which
require their type of expertise.
Substantial segments of the upcoming
SEP meeting listed below will be closed
to the public in accordance with the
Federal Advisory Committee Act,
section 10(d) of 5 U.S.C., Appendix 2
and 5 U.S.C. 552b(c)(6). Grant
applications for the OS ARRA:
Expansion of Research Capabilities to
Study CE Complex Patients (R24)
applications are to be reviewed and
discussed at this meeting. These
discussions are likely to reveal personal
information concerning individuals
associated with the applications. This
information is exempt from mandatory
disclosure under the above-cited
statutes.
SEP Meeting on: OS ARRA: Expansion of
Research Capabilities to Study CE Complex
Patients (R24).
Date: April 5–6, 2010 (Open on April 5
from 8 a.m. to 8:15 a.m. and closed for the
remainder of the meeting).
Place: Bethesda North Marriott, 5701
Marinelli Road, Conference Room TBD,
Bethesda, Maryland 20852.
Contact Person: Anyone wishing to obtain
a roster of members, agenda or minutes of the
nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell,
Committee Management Officer, Office of
Extramural Research, Education and Priority
Populations, AHRQ, 540 Gaither Road, Room
2038, Rockville, Maryland 20850, Telephone
(301) 427–1554.
E:\FR\FM\18MRN1.SGM
18MRN1
]]>Agencies
[Federal Register Volume 75, Number 52 (Thursday, March 18, 2010)]
[Notices]
[Pages 13134-13135]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5744]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
In accordance with section 10(d) of the Federal Advisory Committee
Act (5 U.S.C., Appendix 2), announcement is made of a Health Care
Policy and
[[Page 13135]]
Research Special Emphasis Panel (SEP) meeting.
A Special Emphasis Panel is a group of experts in fields related to
health care research who are invited by the Agency for Healthcare
Research and Quality (AHRQ), and agree to be available, to conduct on
an as needed basis, scientific reviews of applications for AHRQ
support. Individual members of the Panel do not attend regularly-
scheduled meetings and do not serve for fixed terms or a long period of
time. Rather, they are asked to participate in particular review
meetings which require their type of expertise.
Substantial segments of the upcoming SEP meeting listed below will
be closed to the public in accordance with the Federal Advisory
Committee Act, section 10(d) of 5 U.S.C., Appendix 2 and 5 U.S.C.
552b(c)(6). Grant applications for the Medical Liability and Safety
Innovation Projects (R21) applications are to be reviewed and discussed
at this meeting. These discussions are likely to reveal personal
information concerning individuals associated with the applications.
This information is exempt from mandatory disclosure under the above-
cited statutes.
SEP Meeting on: Medical Liability and Safety Innovation Projects
(R2l)
Date: April 2, 2010 (Open on April 2 from 8 a.m. to 8:15 a.m.
and closed for the remainder of the meeting)
Place: Doubletree Bethesda Hotel & Executive Meeting Center,
8120 Wisconsin Avenue, Conference Room TBD, Bethesda, Maryland
20852.
Contact Person: Anyone wishing to obtain a roster of members,
agenda or minutes of the nonconfidential portions of this meeting
should contact Mrs. Bonnie Campbell, Committee Management Officer,
Office of Extramural Research, Education and Priority Populations,
AHRQ, 540 Gaither Road, Room 2038, Rockville, Maryland 20850,
Telephone (301) 427-1554.
Agenda items for this meeting are subject to change as
priorities dictate.
This notice is published less than 15 days in advance of the
meeting date due to logistical difficulties.
Dated: March 8, 2010.
Carolyn M. Clancy,
Director.
[FR Doc. 2010-5744 Filed 3-17-10; 8:45 am]
BILLING CODE 4160-90-M
